Mónica Flores-Muñoz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mónica Flores-Muñoz has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Rossana Citlali Zepeda
Laboratorio de Biomedicina Integral y Salud, Centro de Investigaciones Biomédicas, Universidad Veracruzana, Xalapa, Mexico
5 shared publications - Claudia Juárez-Portilla
Centro de Investigaciones Biomédicas, Universidad Veracruzana, Xalapa, Veracruz, México
4 shared publications - Oscar Lopez-Franco
Laboratorio de Medicina Traslacional, Instituto de Ciencias de la Salud Universidad Veracruzana Xalapa Mexico
4 shared publications - Tania Molina-Jiménez
Laboratory of Integral Biomedicine and Health, Biomedical Research Center, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
4 shared publications - Diana I. Del Moral
Laboratorio de Medicina Traslacional, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Mexico
2 shared publications Gisela Aguirre
Laboratorio de Neurobiología de la Conducta y Procesos Neuroquímicos, Centro de Investigaciones Biomédicas Universidad Veracruzana Xalapa Veracruz Mexico
2 shared publications
Latest Publications
- Open Access
- 12 March 2026
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 38 (3) , e70162
Ovarian influence on circadian and infradian modulation of nicotine‐seeking in female mice
Sex differences in tobacco intake are closely associated with hormonal fluctuations during the menstrual cycle in women. Elevated estrogen levels have been associated with increased stress, which may lead to a higher likelihood of seeking psychoactive substances. Additionally, tobacco use has been associated with negative effects on reproductive health. Preclinical studies suggested that the estrous cycle significantly influences addictive behaviors, emphasizing the role of ovarian hormones. Furthermore, psychoactive substances entrain circadian rhythms, with animals showing increased locomotor activity 1–2 h before drug administration time, known as anticipatory activity, reflecting seeking behavior. This study aims to evaluate the impact of ovarian hormones on nicotine‐anticipatory behavior. A circadian model of forced administration of nicotine via nebulization was implemented in intact and ovariectomized female mice, exposing them to nicotine at a fixed time (ZT4) for 20 min daily over 14 days. The effects of nicotine intake on ovarian follicle morphology and maturation were also assessed. Daily nicotine exposure successfully entrained a clear anticipatory behavior in intact mice. Notably, this anticipatory activity was completely abolished in ovariectomized females, indicating a critical dependence on ovarian factors. Furthermore, nicotine exposure disrupted the estrous cycle and induced significant ovarian follicular damage in intact females. Our findings suggest that the hormonal state is a primary modulator of nicotine‐anticipatory behavior. Moreover, the observed nicotine‐induced ovarian damage highlights a significant risk to female reproductive health, suggesting a bidirectional relationship between nicotine use and the hypothalamic–pituitary–gonadal axis.
- 12 March 2026
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 38 (3) , e70162
Open AccessOvarian influence on circadian and infradian modulation of nicotine‐seeking in female mice
Sex differences in tobacco intake are closely associated with hormonal fluctuations during the menstrual cycle in women. Elevated estrogen levels have been associated with increased stress, which may lead to a higher likelihood of seeking psychoactive substances. Additionally, tobacco use has been associated with negative effects on reproductive health. Preclinical studies suggested that the estrous cycle significantly influences addictive behaviors, emphasizing the role of ovarian hormones. Furthermore, psychoactive substances entrain circadian rhythms, with animals showing increased locomotor activity 1–2 h before drug administration time, known as anticipatory activity, reflecting seeking behavior. This study aims to evaluate the impact of ovarian hormones on nicotine‐anticipatory behavior. A circadian model of forced administration of nicotine via nebulization was implemented in intact and ovariectomized female mice, exposing them to nicotine at a fixed time (ZT4) for 20 min daily over 14 days. The effects of nicotine intake on ovarian follicle morphology and maturation were also assessed. Daily nicotine exposure successfully entrained a clear anticipatory behavior in intact mice. Notably, this anticipatory activity was completely abolished in ovariectomized females, indicating a critical dependence on ovarian factors. Furthermore, nicotine exposure disrupted the estrous cycle and induced significant ovarian follicular damage in intact females. Our findings suggest that the hormonal state is a primary modulator of nicotine‐anticipatory behavior. Moreover, the observed nicotine‐induced ovarian damage highlights a significant risk to female reproductive health, suggesting a bidirectional relationship between nicotine use and the hypothalamic–pituitary–gonadal axis.
- Open Access
- 24 October 2025
- Published by Universidad Veracruzana in UVserva
- No. 20
Relación de componentes del síndrome metabólico y parámetros periodontales de pacientes con DM2
Introducción.La enfermedad periodontal (EP) es una patología crónica inflamatoria que destruye los tejidos de soporte dental y provocan la perdida de dientes. Esta se relaciona con el Sindrome metabólico (SM) que incluye obesidad, dislipidemia e hipertensión, que sumados a los parámetros de EP contribuyen con el aumento de problemas cardiovasculares. Objetivo: Evaluar la relación entre los componentes del SM y parametros de EP en pacientes con DM2. Metodología: Estudio descriptivo y correlacional. Se analizaron 39 instrumentos clínicos de pacientes con EP y DM2 de un Hospital de Alta Especialidad, en Xalapa, Veracruz. Resultados: Se identificaron correlaciones significativas entre: niveles de sangrado al sondeo y niveles de glucosa (r=0.3452, p=0.0214), tensión arterial media y niveles de inserción clínica (r=0.3322, p=0.0268), sangrado al sondeo y tensión arterial media (r=0.5346, p=0.0268). Conclusión: Se observó una relación directa entre los componentes del Síndrome Metabólico y los parámetros clínicos de la enfermedad periodontal.
- 24 October 2025
- Published by Universidad Veracruzana in UVserva
- No. 20
Open AccessRelación de componentes del síndrome metabólico y parámetros periodontales de pacientes con DM2
Introducción.La enfermedad periodontal (EP) es una patología crónica inflamatoria que destruye los tejidos de soporte dental y provocan la perdida de dientes. Esta se relaciona con el Sindrome metabólico (SM) que incluye obesidad, dislipidemia e hipertensión, que sumados a los parámetros de EP contribuyen con el aumento de problemas cardiovasculares. Objetivo: Evaluar la relación entre los componentes del SM y parametros de EP en pacientes con DM2. Metodología: Estudio descriptivo y correlacional. Se analizaron 39 instrumentos clínicos de pacientes con EP y DM2 de un Hospital de Alta Especialidad, en Xalapa, Veracruz. Resultados: Se identificaron correlaciones significativas entre: niveles de sangrado al sondeo y niveles de glucosa (r=0.3452, p=0.0214), tensión arterial media y niveles de inserción clínica (r=0.3322, p=0.0268), sangrado al sondeo y tensión arterial media (r=0.5346, p=0.0268). Conclusión: Se observó una relación directa entre los componentes del Síndrome Metabólico y los parámetros clínicos de la enfermedad periodontal.
- Open Access
- 8 June 2025
- Published by Wiley in Addiction Biology
- Vol. 30 (6) , e70046
Ovarian Hormones and Addictive Behaviour Vulnerability: Insights From Preclinical Studies
Substance use disorder constitutes a global health challenge. Preclinical investigations into addiction heavily rely on animal models to explore the underlying biological mechanisms of addictive disorders, with a particular emphasis on understanding the etiological factors influencing drug intake. Exploring sex differences across various phases of addiction has revealed a heightened vulnerability in females. This study systematically reviews the impact of ovarian hormones on the consumption of psychoactive substances in rodents, adhering to the PRISMA 2009 protocol. Our findings underscore the significant role of ovarian hormones, particularly oestrogen, in augmenting drug consumption among female rodents. Notably, with heroin, it was observed that progesterone, rather than oestrogen, facilitated increased consumption in female rodents. The susceptibility to addiction influenced by oestrogen is accentuated across distinct phases, and the molecular mechanisms form a complex interplay that significantly influences addictive behaviours. By bringing together these findings, we aim to establish a strong foundation for future studies. This work may guide clinical investigations in developing more effective prevention or treatment strategies that address the unique vulnerabilities of females to substance use disorders.
- 8 June 2025
- Published by Wiley in Addiction Biology
- Vol. 30 (6) , e70046
Open AccessOvarian Hormones and Addictive Behaviour Vulnerability: Insights From Preclinical Studies
Substance use disorder constitutes a global health challenge. Preclinical investigations into addiction heavily rely on animal models to explore the underlying biological mechanisms of addictive disorders, with a particular emphasis on understanding the etiological factors influencing drug intake. Exploring sex differences across various phases of addiction has revealed a heightened vulnerability in females. This study systematically reviews the impact of ovarian hormones on the consumption of psychoactive substances in rodents, adhering to the PRISMA 2009 protocol. Our findings underscore the significant role of ovarian hormones, particularly oestrogen, in augmenting drug consumption among female rodents. Notably, with heroin, it was observed that progesterone, rather than oestrogen, facilitated increased consumption in female rodents. The susceptibility to addiction influenced by oestrogen is accentuated across distinct phases, and the molecular mechanisms form a complex interplay that significantly influences addictive behaviours. By bringing together these findings, we aim to establish a strong foundation for future studies. This work may guide clinical investigations in developing more effective prevention or treatment strategies that address the unique vulnerabilities of females to substance use disorders.
- Open Access
- 10 April 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1377113
Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?
The renin-angiotensin system (RAS) is an important cascade of enzymes and peptides that regulates blood pressure, volume, and electrolytes. Within this complex system of reactions, its counter-regulatory axis has attracted attention, which has been associated with the pathophysiology of inflammatory and fibrotic diseases. This review article analyzes the impact of different components of the counter-regulatory axis of the RAS on different pathologies. Of these peptides, Angiotensin-(1–7), angiotensin-(1–9) and alamandine have been evaluated in a wide variety of in vitro and in vivo studies, where not only they counteract the actions of the classical axis, but also exhibit independent anti-inflammatory and fibrotic actions when binding to specific receptors, mainly in heart, kidney, and lung. Other functional peptides are also addressed, which despite no reports associated with inflammation and fibrosis to date were found, they could represent a potential target of study. Furthermore, the association of agonists of the counter-regulatory axis is analyzed, highlighting their contribution to the modulation of the inflammatory response counteracting the development of fibrotic events. This article shows an overview of the importance of the RAS in the resolution of inflammatory and fibrotic diseases, offering an understanding of the individual components as potential treatments.
- 10 April 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1377113
Open AccessCounter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?
The renin-angiotensin system (RAS) is an important cascade of enzymes and peptides that regulates blood pressure, volume, and electrolytes. Within this complex system of reactions, its counter-regulatory axis has attracted attention, which has been associated with the pathophysiology of inflammatory and fibrotic diseases. This review article analyzes the impact of different components of the counter-regulatory axis of the RAS on different pathologies. Of these peptides, Angiotensin-(1–7), angiotensin-(1–9) and alamandine have been evaluated in a wide variety of in vitro and in vivo studies, where not only they counteract the actions of the classical axis, but also exhibit independent anti-inflammatory and fibrotic actions when binding to specific receptors, mainly in heart, kidney, and lung. Other functional peptides are also addressed, which despite no reports associated with inflammation and fibrosis to date were found, they could represent a potential target of study. Furthermore, the association of agonists of the counter-regulatory axis is analyzed, highlighting their contribution to the modulation of the inflammatory response counteracting the development of fibrotic events. This article shows an overview of the importance of the RAS in the resolution of inflammatory and fibrotic diseases, offering an understanding of the individual components as potential treatments.
- 1 March 2022
- Published by Elsevier in Endocrinología, Diabetes y Nutrición
- Vol. 69 (3) , 168-177
Effects on cardiometabolic risk factors after reduction of artificially sweetened beverage consumption in overweight subjects. A randomised controlled trial
- 1 March 2022
- Published by Elsevier in Endocrinología, Diabetes y Nutrición
- Vol. 69 (3) , 168-177
Effects on cardiometabolic risk factors after reduction of artificially sweetened beverage consumption in overweight subjects. A randomised controlled trial
- Open Access
- 5 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 11977
CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice
CD38 is a transmembrane glycoprotein expressed by T-cells. It has been reported that patients with systemic lupus erythematosus (SLE) showed increased CD38+CD25+ T-cells correlating with immune activation and clinical signs. Contrariwise, CD38 deficiency in murine models has shown enhanced autoimmunity development. Recent studies have suggested that CD38+ regulatory T-cells are more suppressive than CD38− regulatory T-cells. Thus, we have suggested that CD38 overexpression in SLE patients could play a role in regulating immune activation cells instead of enhancing it. This study found a correlation between CD38 with FoxP3 expression and immunosuppressive molecules (CD69, IL-10, CTLA-4, and PD-1) in T-cells from lupus-prone mice (B6.MRL-Faslpr/J). Additionally, B6.MRL-Faslpr/J mice showed a decreased proportion of CD38+ Treg cells regarding wild-type mice (WT). Furthermore, Regulatory T-Cells (Treg cells) from CD38-/- mice showed impairment in expressing immunosuppressive molecules and proliferation after stimulation through the T-cell receptor (TCR). Finally, we demonstrated an increased ratio of IFN-γ/IL-10 secretion in CD38-/- splenocytes stimulated with anti-CD3 compared with the WT. Altogether, our data suggest that CD38 represents an element in maintaining activated and proliferative Treg cells. Consequently, CD38 could have a crucial role in immune tolerance, preventing SLE development through Treg cells.
- 5 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 11977
Open AccessCD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice
CD38 is a transmembrane glycoprotein expressed by T-cells. It has been reported that patients with systemic lupus erythematosus (SLE) showed increased CD38+CD25+ T-cells correlating with immune activation and clinical signs. Contrariwise, CD38 deficiency in murine models has shown enhanced autoimmunity development. Recent studies have suggested that CD38+ regulatory T-cells are more suppressive than CD38− regulatory T-cells. Thus, we have suggested that CD38 overexpression in SLE patients could play a role in regulating immune activation cells instead of enhancing it. This study found a correlation between CD38 with FoxP3 expression and immunosuppressive molecules (CD69, IL-10, CTLA-4, and PD-1) in T-cells from lupus-prone mice (B6.MRL-Faslpr/J). Additionally, B6.MRL-Faslpr/J mice showed a decreased proportion of CD38+ Treg cells regarding wild-type mice (WT). Furthermore, Regulatory T-Cells (Treg cells) from CD38-/- mice showed impairment in expressing immunosuppressive molecules and proliferation after stimulation through the T-cell receptor (TCR). Finally, we demonstrated an increased ratio of IFN-γ/IL-10 secretion in CD38-/- splenocytes stimulated with anti-CD3 compared with the WT. Altogether, our data suggest that CD38 represents an element in maintaining activated and proliferative Treg cells. Consequently, CD38 could have a crucial role in immune tolerance, preventing SLE development through Treg cells.
- Open Access
- 28 May 2021
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 15, 694239
Corrigendum: Cognitive Impairment After Resolution of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis
Corrigendum: Cognitive Impairment After Resolution of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis
- 28 May 2021
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 15, 694239
Open AccessCorrigendum: Cognitive Impairment After Resolution of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis
Corrigendum: Cognitive Impairment After Resolution of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis
- Open Access
- 16 September 2020
- Published by Wiley in Journal of Nutrition and Metabolism
- Vol. 2020, 1-9
Lugol Increases Lipolysis through Upregulation of PPAR-Gamma and Downregulation of C/EBP-Alpha in Mature 3T3-L1 Adipocytes
Overweight and obesity are defined as excessive and abnormal fat accumulation that is harmful to health. This study analyzes the effect of different concentrations of the lugol solution (molecular iodine dissolved in potassium iodide) on lipolysis in cultured 3T3-L1-differentiated adipocytes. The mature adipocytes were treated with doses from 1 to 100 µm of lugol for 0.5, 6, and 24 h. The results showed that mature adipocytes exposed to lugol decrease their viability and increase caspase-3 activity with a lethal dose (LD50) of 473 µm. In mature adipocytes, lugol decreased the total intracellular lipid content, being significant at doses of 10 and 100 µm after 6 and 24 h of treatment (), and the accumulation of intracellular triglycerides decreased after 24 h of exposure to lugol (). Lugol treatment significantly increases the release of glycerol to the culture medium (). The levels of adipocyte-specific transcription factors C/EBP-αwere downregulated and PPAR-γupregulated after 30 min with lugol. These results indicate a lipolytic effect of lugol dependent on PPAR-γand C/EBP-αexpression in mature 3T3-L1 adipocytes.- 16 September 2020
- Published by Wiley in Journal of Nutrition and Metabolism
- Vol. 2020, 1-9
Open AccessLugol Increases Lipolysis through Upregulation of PPAR-Gamma and Downregulation of C/EBP-Alpha in Mature 3T3-L1 Adipocytes
Overweight and obesity are defined as excessive and abnormal fat accumulation that is harmful to health. This study analyzes the effect of different concentrations of the lugol solution (molecular iodine dissolved in potassium iodide) on lipolysis in cultured 3T3-L1-differentiated adipocytes. The mature adipocytes were treated with doses from 1 to 100 µm of lugol for 0.5, 6, and 24 h. The results showed that mature adipocytes exposed to lugol decrease their viability and increase caspase-3 activity with a lethal dose (LD50) of 473 µm. In mature adipocytes, lugol decreased the total intracellular lipid content, being significant at doses of 10 and 100 µm after 6 and 24 h of treatment (), and the accumulation of intracellular triglycerides decreased after 24 h of exposure to lugol (). Lugol treatment significantly increases the release of glycerol to the culture medium (). The levels of adipocyte-specific transcription factors C/EBP-αwere downregulated and PPAR-γupregulated after 30 min with lugol. These results indicate a lipolytic effect of lugol dependent on PPAR-γand C/EBP-αexpression in mature 3T3-L1 adipocytes. - 1 October 2019
- Published by Elsevier in Phytomedicine
- Vol. 63, 153016
Seaweeds-derived compounds modulating effects on signal transduction pathways: A systematic review
- 1 October 2019
- Published by Elsevier in Phytomedicine
- Vol. 63, 153016
Seaweeds-derived compounds modulating effects on signal transduction pathways: A systematic review